Trials / Suspended
SuspendedNCT01174979
Caroverin and Inner Ear Diseases
Double Blind, Placebo-controlled, Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Transtympanic Treatment of Tinnitus With Caroverine
- Status
- Suspended
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- Sponsor
- Phafag AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial is a randomized, double blind, placebo controlled study on patients suffering from inner ear diseases with tinnitus as a principal symptom. The study will investigate the transtympanic treatment with a 1,5 % caroverine solution. Each patient will undergo treatment for 2 cycles of 48 hours each.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Caroverin | treatment with eardrops 2 times for 48 hours |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2015-08-01
- First posted
- 2010-08-04
- Last updated
- 2015-08-07
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01174979. Inclusion in this directory is not an endorsement.